Insulin aspart is a rapid-acting form of insulin used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes. Insulin is typically prescribed for the management of diabetes mellitus to mimic the activity of endogenously produced human insulin, a peptide hormone produced by beta cells of the pancreas that promotes glucose metabolism. Insulin ...
Insulin aspart is indicated to improve glycemic control in adults and children with diabetes mellitus.
UT Southwestern at Dallas, Dallas, Texas, United States
UT MD Anderson Cancer Center, Houston, Texas, United States
Novo Nordisk Investigational Site, Watford, United Kingdom
Novo Nordisk Investigational Site, Kocaeli, Turkey
Clinical Translational Unit - Tulane School of Medicine, New Orleans, Louisiana, United States
Aarhus University Hospital, department of Endocrinology and Diabetes, Aarhus C, Aarhus, Denmark
Novo Nordisk Investigational Site, Norfolk, United Kingdom
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.